These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9590387)

  • 1. Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood.
    Jung K; Laube C; Lein M; Lichtinghagen R; Tschesche H; Schnorr D; Loening SA
    Clin Chem; 1998 May; 44(5):1060-2. PubMed ID: 9590387
    [No Abstract]   [Full Text] [Related]  

  • 2. Analytical aspects regarding the measurement of metalloproteinases.
    Lein M; Jung K; Nowak L; Schnorr D; Loening SA
    Ann N Y Acad Sci; 1999 Jun; 878():491-3. PubMed ID: 10415751
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated plasma gelatinase A (MMP-2) activity is associated with quiescent Crohn's Disease.
    Kossakowska AE; Medlicott SA; Edwards DR; Guyn L; Stabbler AL; Sutherland LR; Urbanski SJ
    Ann N Y Acad Sci; 1999 Jun; 878():578-80. PubMed ID: 10415778
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of anticoagulants on the activity of gelatinases.
    Castellazzi M; Tamborino C; Fainardi E; Manfrinato MC; Granieri E; Dallocchio F; Bellini T
    Clin Biochem; 2007 Nov; 40(16-17):1272-6. PubMed ID: 17904541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of specimen collection in preanalytical variation of metalloproteinases and their inhibitors in blood.
    Jung K; Nowak L; Lein M; Henke W; Schnorr D; Loening SA
    Clin Chem; 1996 Dec; 42(12):2043-5. PubMed ID: 8969650
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
    Iizasa T; Fujisawa T; Suzuki M; Motohashi S; Yasufuku K; Yasukawa T; Baba M; Shiba M
    Clin Cancer Res; 1999 Jan; 5(1):149-53. PubMed ID: 9918213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities.
    Gerlach RF; Uzuelli JA; Souza-Tarla CD; Tanus-Santos JE
    Anal Biochem; 2005 Sep; 344(1):147-9. PubMed ID: 15950912
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
    Endo K; Maehara Y; Baba H; Yamamoto M; Tomisaki S; Watanabe A; Kakeji Y; Sugimachi K
    Anticancer Res; 1997; 17(3C):2253-8. PubMed ID: 9216697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis.
    Walsh KM; Timms P; Campbell S; MacSween RN; Morris AJ
    Dig Dis Sci; 1999 Mar; 44(3):624-30. PubMed ID: 10080160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and partial characterization of three calcium- and zinc-independent gelatinases constitutively present in human circulation.
    Makowski GS; Ramsby ML
    Biochem Mol Biol Int; 1998 Dec; 46(5):1043-53. PubMed ID: 9861458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.
    Kai H; Ikeda H; Yasukawa H; Kai M; Seki Y; Kuwahara F; Ueno T; Sugi K; Imaizumi T
    J Am Coll Cardiol; 1998 Aug; 32(2):368-72. PubMed ID: 9708462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer.
    Gohji K; Fujimoto N; Ohkawa J; Fujii A; Nakajima M
    Br J Cancer; 1998 Feb; 77(4):650-5. PubMed ID: 9484825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
    Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
    Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase and tissue inhibitor of metalloproteinase regulation of the invasive potential of a metastatic renal cell line.
    McElligott AM; Baker AH; McGlynn H
    Biochem Soc Trans; 1997 Feb; 25(1):147S. PubMed ID: 9057045
    [No Abstract]   [Full Text] [Related]  

  • 15. Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome.
    Hopps E; Lo Presti R; Montana M; Noto D; Averna MR; Caimi G
    J Investig Med; 2013 Aug; 61(6):978-83. PubMed ID: 23661104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane.
    Fortunato SJ; Menon R; Lombardi SJ
    Am J Obstet Gynecol; 1997 Oct; 177(4):731-41. PubMed ID: 9369811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.
    Wojtowicz-Praga S; Torri J; Johnson M; Steen V; Marshall J; Ness E; Dickson R; Sale M; Rasmussen HS; Chiodo TA; Hawkins MJ
    J Clin Oncol; 1998 Jun; 16(6):2150-6. PubMed ID: 9626215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with liver disease.
    Ebata M; Fukuda Y; Nakano I; Katano Y; Fujimoto N; Hayakawa T
    Liver; 1997 Dec; 17(6):293-9. PubMed ID: 9455735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
    Rosell A; Alvarez-Sabín J; Arenillas JF; Rovira A; Delgado P; Fernández-Cadenas I; Penalba A; Molina CA; Montaner J
    Stroke; 2005 Jul; 36(7):1415-20. PubMed ID: 15947272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection.
    Gohji K; Fujimoto N; Fujii A; Komiyama T; Okawa J; Nakajima M
    Cancer Res; 1996 Jul; 56(14):3196-8. PubMed ID: 8764105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.